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1. Abstract
Purpose/Objective: Linac backscattered radiation (BSR) into the monitor chamber affects the15
chamber’s signal and has to be accounted for in radiotherapy dose calculations. In Monte Carlo
(MC) calculations, the BSR can be modeled explicitly and accounted for in absolute dose.
However, explicit modelling of the BSR becomes impossible if treatment head geometry is not
available. In this study, monitor backscatter factors (MBSFs), defined as the ratio of the charge
collected in the monitor chamber for a reference field to that of a given field, have been20
evaluated experimentally and incorporated into MC modelling of linacs with either known or
unknown treatment head geometry.
Materials and methods: A telescopic technique similar to that by Kubo (1989) was used.
However, instead of lead slits, a 1.8 mm diameter collimator and a small (2 mm diameter)
detector positioned at extended SDD were used. This setup provided a field of view to the source25
of less than 3.1 mm and allowed for MBSF measurements of open fields from 1 x 1 to 40 x 40
cm2. For the fields with both X and Y dimensions exceeding 15 cm, a diode detector was used. A
pinpoint ionization chamber was used for smaller fields. MBSFs were also explicitly modeled in
MC calculations using BEAMnrc and DOSXYZnrc codes for 6MV and 18MV beams of a Varian
21EX linac. A method for deriving the Dchforward values that are used in MC absolute dose30
calculations was demonstrated. These values were derived from measured MBSFs for two 21EX
and four TrueBeam energies.
Results: MBSFs were measured for 6MV and 18MV beams from Varian 21EX, and for 6MV,
10MV-FFF, 10MV, and 15MV beams from Varian TrueBeam linacs. For the open field sizes
modeled in this study for the 21EX, the measured MBSFs agreed with MC calculated values35
within combined statistical (0.4%) and experimental (0.2%) uncertainties. Variation of MBSFs
across field sizes was about a factor of two smaller for the TrueBeam compared to 21EX Varian
linacs.
Conclusions: Measured MBSFs and the derived Dchforward factors allow for the incorporation of
the BSR effect into accurate radiotherapy dose calculations without explicit backscatter40
modelling.
2. Introduction
Backscattered radiation (BSR) from secondary collimators into the monitor chamber affects linac
dose calibration and it has been investigated in the past both experimentally and using Monte
Carlo (MC) modelling. Experimental measurement methods include using a backscatter filter45
technique (Luxton and Astrahan, 1988), the telescopic technique by Kubo (Kubo, 1989) and its
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variations, pulse counting and target charge measuring techniques. AAPM Task Group Report 74
(Zhu, Ahnesjo et al., 2009) provides a concise but comprehensive summary of these studies.
To date, the telescopic technique has been recognized as the most reliable non-invasive method50
for measurement of the BSR (Yu, Sloboda et al., 1996, Zhu, Ahnesjo et al., 2009). However, it is
cumbersome to use due to the heavy lead blocks required for collimation. Modifications to this
technique that use smaller collimators have been tested (Duzenli, McClean et al., 1993), but
suffered from overestimation of the BSR due to inadvertent inclusion of room scatter into the
measured signal (Yu, Sloboda et al., 1996). Yu and Sanz (Yu, Sloboda et al., 1996, Sanz, Alvarez55
et al., 2007) improved this technique by evaluating and subtracting the scatter component of the
signal, though Sanz et al used a small lead slug instead of collimators. Evaluation of the room
scatter required doubling the number of measurements.
Understanding and evaluating the BSR impact on dose calculations has so far been largely of60
academic interest – in clinical dose calculation this factor has been incorporated and “hidden”
within the collimator factor Sc that is commonly measured during treatment machine
commissioning. Sc contains the monitor backscatter factor Sb as well as the head scatter factor Sh
in the product Sc = Sh x Sb, but neither Sh or Sb are used explicitly. Instead, the total scatter factor
Sc,p is also measured, and the phantom scatter factor (that is used in the calculations) is derived as65
their ratio: Sp = Sc,p / Sc.
In contrast, none of these empirically derived factors are required for use in Monte Carlo based
dose calculations, as their effect is explicitly modelled during radiation transport through the
linac head and into the phantom. However, the importance of Sb factor measurements has risen70
dramatically with increased use of manufacturers’ phase-spaces as well as simplified source
models in place of full radiation transport through the linac head. Explicit modelling of the BSR
is impossible or impractical in such situations and experimental Sb values must be used instead.
Measurement of the Sb factor then becomes one of the key elements in absolute dose
calculations.75
The purpose of this study is to evaluate experimentally and incorporate into MC modelling the
monitor backscatter factors (MBSFs), defined as the ratio of the charge collected in the beam
monitor chamber for a reference field to that of a given field.
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The novelty of the current paper is as follows: (1) improvement and simplification of the
telescopic technique compared to its previous versions; (2) validation of the measurement
technique by independent Monte Carlo modelling of Sb factors for the Varian 21EX clinac (for
which the geometry and composition was modeled from the manufacturer’s specifications); (3)
measurement of Sb factors for Varian TrueBeam linear accelerator beams; (4) development of a85
simple technique for the derivation of forward fluence dose to the linac monitor chamber; (5)
calculation of this forward fluence dose for two 21EX and four TrueBeam energies.
3. Materials and Methods
2.1 Monitor backscatter factors
In the early publications by Kubo and Duzenli, the effect of the BSR was quantified simply as90
“relative charge reading” or “relative output”. Later, Liu et al (Liu, Mackie et al., 2000)
introduced the factor Scb, defined as “the change of photon output caused by the backscatter”,
which was subsequently simplified to the “monitor-backscatter factor” Sb by Zhu et al (Zhu,
Kang et al., 2006, Zhu, Ahnesjo et al., 2009). We will use the same terminology for consistency
with the recent literature.95
3Zhu et al (2006) used the definition of Sb in the BSR pulse measuring technique as the ratio of
the number of electron pulses NP(X,Y) measured on the target for the field size (X,Y) to that for a
reference field (Xr,Yr). AAPM task group report 74 (Zhu, Ahnesjo et al., 2009) defines Sb through
a less intuitive ratio100
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where A and Aref are aperture settings for an arbitrary and reference field, respectively,
b=MUb/MU0, and with MUb and MU0 being backscatter and direct monitor chamber signals.105
Noticing that direct signal is independent of the field size, this equation simplifies to a much
more intuitive definition as the ratio of the signal from the beam monitor chamber for a reference
field to that of a given field:
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This definition is inverted compared to the common definitions of other output factors that are
defined relative to a reference signal. However, since monitor chamber signal is inverse to the
detector reading collected in telescopic BSR measurements, this definition is consistent with the
original “relative charge readings” by Kubo. It is also consistent with the relative measurements115
in our modified telescopic technique (which excludes room scatter from the signal). In the
telescopic technique this factor is therefore directly measured as
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2.2 Experimental setup and measurements120
We used a telescopic technique similar to that by Kubo (Kubo, 1989). Instead of narrow slits, a
set of decommissioned Brainlab circular stereotactic collimators was used. The height and outer
diameter of each collimator was 11.4 and 6.7 cm, respectively. One of the collimators was
modified in-house to provide an aperture size of 1.8 mm in diameter, and it was attached to the
treatment head using a standard Brainlab stereotactic collimator holder. The distance from the125
bottom of this collimator to the source was 73.5 cm. Four other collimators were stacked on the
couch at its lowest position, with the smallest (5 mm aperture) collimator being closest to the
source. This produced a well-type structure to act as a detector housing and provide shielding
from head scattered radiation and room scatter. A PTW pinpoint ionization chamber (effective
volume 0.0125 cm3 and effective diameter 2 mm) with a small PMMA build-up cap was130
positioned inside this well-type structure at a 150 cm source to detector distance (SDD), as
shown in figure 1. The chamber was tightly fitted to the aperture of the lower collimator. This
setup allows for accurate alignment of the apparatus in the beam (using the light field and lasers)
and was found to provide high reproducibility of the measurements.
135
The in-field portion of the chamber cable was shielded by lead blocks to remove extra-chamber
signal. Despite this, it was found that lead shielded cable current for large (over 15 x 15 cm2)
square fields still contributed up to 0.9% to the measured MBSFs for beams with energies of 10
MV and over. These large fields were therefore measured using a diode detector with a 2 mm
diameter effective measurement volume. The diode detector is appropriate for MBSF140
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measurements in our setup because only the signal from the narrow collimated beam is
measured, with no spectral variations occurring over different field sizes.
Figure 1. The experimental setup for measurement of Sb factors. The 1.8 cm diameter collimator that was attached
to the treatment head using a BrainLab SRS collimator holder is shown. Also shown are four collimators stacked on145
the couch top, providing a well-type structure for housing a PinPoint ionization chamber. The aperture of the top
collimator was 5 mm. Inset: zoom-in of the IC with a small PMMA build-up cap, positioned inside the well-
structure. Lead blocks that were used for chamber cable shielding are not shown. For large fields, a diode detector
was used in place of the ionization chamber shown in the diagram.
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This setup provided a field of view to the source of less than 3.1 mm, allowing for the
measurement of Sb factors for field sizes in the range of 1 x 1 to 40 x 40 cm2.
In order to evaluate the level of the room scatter in the measured signal, a 2 cm diameter and 39
cm length steel rod was placed vertically on the top of detector housing collimator stack,155
blocking the primary signal. Measurements were taken for the highest available energy, 18 MV,
for 10 x 10 and 40 x 40 cm2 fields. Neither of these measurements detected any signal
confirming negligible level of the room scatter contribution to the measured MBSFs.
One of the advantages of this setup was its high accuracy and reproducibility. The Brainlab160
stereotactic collimator holder has alignment screws to accurately centre the collimator in the
beam. Once alignment was completed during the first measurement session, it was highly
reproducible during subsequent sessions that were needed for measuring Sb factors for different
beams. The setup time for these sessions was on the order of 20 minutes.
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The primary source of errors in these measurements was found to be signal drift due to instability
of the machine output and pressure / temperature changes. Frequent (every 5 - 10 measurement
points) reference measurements were taken to reduce effect of this drift and minimize
measurement error.
170
Reproducibility of the setup and the measured data were verified by doing “spot check”
measurements for all of the beams on different days (15MV and 18MV data sets have been re-
measured completely). Additionally, these measurements were performed using a different
1.8 mm diameter
collimator
150 cm SDD
Couch
76.5 cm Build-up cap
11.4 cm
Pin point IC positioned inside
the well-structure
11.4 cm
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detector (diode vs. PinPoint ionization chamber).
175
Experimental measurements were performed for 6MV and 18MV beams from the Varian 21EX,
and for 6MV, 10MV, 10MV-FFF and 15MV TrueBeam linac beams. Three readings were taken
per field size at 100 monitor units each. These readings, along with reproducibility measurements
were used to evaluate uncertainties in the reported Sb values.
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An in-house sliding average filter was applied to the measured data to remove non-physical
anomalies where Sb factors decreased slightly with increasing field size. These corrections were
very small, with majority of them being well within 0.1%. Only two points out of all the datasets
(for six energies) were altered by 0.12%.
2.3 Incorporation of Sb factors into Monte Carlo dose calculations185
In MC dose calculations the Sb factor can be explicitly accounted for, provided the linac head
geometry is known (Verhaegen, Symonds-Tayler et al., 2000, Popescu, Shaw et al., 2005). In
fact, in our Vancouver Island MC (VIMC) system (Zavgorodni, Bush et al., 2007, Bush,
Townson et al., 2008) we use the absolute dose calculation method (Popescu, Shaw et al., 2005)
that accounts for Sb “on-the-fly”. In this method, the dose is converted from MC dose190
(normalised per “incident electron on the target”), to absolute dose in units of Gy through the
following equation:
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where195
 xyzD is the normalized dose (in Gy per incident particle) scored during MC simulation in
an arbitrary xyz voxel of a water or patient CT phantom.
 absxyzD , is the absolute dose (in Gy) deposited in the voxel where xyzD was scored.
 forwardchD is the normalized dose (in Gy per incident particle) scored during MC simulation
in the monitor chamber of the virtual linac due to direct fluence.200
 backchD is the normalized virtual linac monitor chamber dose (in Gy per incident particle)
due to the BSR.
 cal absxyzD , is the absolute dose (in Gy) at a reference point in calibration geometry.
 calxyzD is the normalized dose (in Gy per incident particle) scored during MC simulation at
a reference point in calibration geometry.205
Taking notice of equation (2) and the fact that monitor chamber signal is proportional to
deposited dose, equation (4) becomes
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and it can be evaluated in MC calculations as described in Popescu et al (Popescu, Shaw et al.,
2005).
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In situations where explicit radiation transport through the linac head geometry is not possible
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due to lack of geometry and material specifications, measured Sb factors could be used through
look-up tables. This is a satisfactory approach, but would involve empirical approximations for
asymmetric fields where measured Sb factors may not exist. Instead, for “virtual TrueBeam”
calibration we propose a simple and more elegant approach that avoids these problems and220
maintains the integrity of absolute dose calibration. This is achieved by using equation (4) again
but with the monitor chamber forward fluence dose being derived from measured Sb factors and
modeled Dchback:
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In cases where the manufacturer has not provided the chamber geometry, any “virtual chamber”225
can be instead simulated using this approach. In this work, the calibration values for TrueBeam
phase-space sources (supplied by the manufacturer) were determined by simulating BSR into a
model of a 21EX chamber. With this model, the Dchback values were calculated as described in
Popescu et al (Popescu, Shaw et al., 2005). As discussed previously by Popescu et al., exact
monitor chamber specifications are not required for absolute dose conversion, and therefore the230
use of the 21EX chamber model does not compromise the accuracy of the calibration method.
This approach simply implies that, had this chamber been mounted in the TrueBeam treatment
head, our derived values of Dchforward and Dchback would have been produced (by that chamber) for
the measured set of Sb factors. Dchforward values have been obtained for four TrueBeam energies
(6MV, 10MV-FFF, 10MV, and 15MV) available in our clinic.235
It was found that Dchforward values are quite sensitive to experimental errors that are inherent in
measured Sb factors, as well as statistical uncertainties in MC simulations of Dchback. In order to
obtain the values of Dchforward that provided the best fit to the measured Sb values, the following
procedure was used for each beam energy. Dchback values were simulated for a variety of field240
sizes, and the measured Sb factors were used to calculate Dchforward for each field size via equation
(7). In an ideal situation with no experimental or statistical errors, all of the Dchforward values
would have been exactly the same. However, due to uncertainties in Sb and Dchback, the Dchforward
values had considerable spreads (from 18% to over 80% for different energies). It is worthwhile
to note that due to the form of equation (6) and the fact that Dchforward is about two orders of245
magnitude greater than Dchback, the Sb factors derived from this equation were not sensitive to
exact value of Dchforward. Using any value of Dchforward from the calculated sets would have
produced agreement with the measured Sb factors within 0.6%. However, it was possible to
considerably improve this agreement. For each of the beam energies, a set of Sbcalc factors was
derived for a range of field sizes from modeled Dchback values and an “approximate” Dchforward250
value using equation (6) in a simple calculation spreadsheet. The mean of the calculated set of
Dchforward values was a good first approximation for a given energy. The value of Dchforward was
then altered iteratively until the best fit of Sbcalc factors to the measured TrueBeam Sb factors was
achieved. As fitting criteria, the root-mean-square deviation between the calculated and
measured Sb values was minimized with no differences |(Sbcalc – Sb)| exceeding 0.1%. This255
procedure provided the “optimized” values of Dchforward, which, when used in MC calculations,
produced Sb factors in close agreement with experiment.
2.4 Monte Carlo modelling of the BSR for comparison with measurement
MC modelling of the BSR was performed using the BEAMnrc code with our 6MV and 18MV
beam models of the Varian 21EX clinac. These models have been thoroughly benchmarked and260
results reported previously (Zavgorodni, Locke et al., 2005, Bush, Zavgorodni et al., 2009, Bush,
Gagné et al., 2011, Zavgorodni, 2013). Sets of 7 and 10 square fields (ranging from 1 x 1 cm2 to
40 x 40 cm2) were used for 6 and 18 MV beams, respectively (see Figures 2 and 3 in Results
section), and Sb factors were calculated using the setup and equations described previously
(Popescu et al., 2005). MC modelling of Sb factors from the TrueBeam was not possible due to265
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lack of manufacturer’s specifications on any components above the jaws. For the TrueBeam
machines, the BSR was modeled using 21EX monitor chamber specifications. For both the
TrueBeam and the 21EX, phase-space sources were scored just above the jaws.
4. Results
3.1 Estimated uncertainties of measured Sb factors270
Inter-reading variations of Sb measurements were within 0.1% for all measured energies and field
sizes with the TrueBeam generally providing more stable readings than the 21EX. Error-
propagated uncertainty estimation of Sb factors for TrueBeam remained at 0.1% level whereas it
increased to be in the range of 0.1%-0.2% for 21EX beams. This estimate was confirmed by
reproducibility measurements. All spot-checked values of Truebeam Sb factors were reproduced275
within 0.1%, and 21EX Sb values were reproduced within 0.2%.
Larger differences of up to 0.5% were found during reproducibility measurements for
fields with an X or Y jaw opening of 1 cm. This was attributed to slightly inaccurate collimator
centering in the initial set of measurements that resulted in the jaws partly shielding the primary
beam signal. Data reported in tables 1-6 reflect more accurate setup that we believe is free from280
this artefact and have the same uncertainty as the rest of the table.
3.2 Sb factors measured for 6MV and 18MV Varian 21EX beams
Tables 1-2 show measured Sb factors for symmetric 6MV and 18MV fields from the Varian
21EX clinac. The factors for a 6MV beam increase from 0.996 for a 1 x 1 cm2 field to 1.014 for a
40 x 40 cm2 field. Corresponding values for an 18MV beam are 0.995 and 1.020. The presented285
data provide sufficient information to be used in dose calculations with analytical head source
models or to derive and verify Dchforward factors for MC models as discussed in the section 2.3.
Table 1. Sb factors measured for a 6MV Varian 21EX and a range of field sizes. Estimated uncertainty of the data
was 0.2%.290
6MV
X, cm
1 2 3 6 10 15 25 40
1 0.996 0.996 0.996 0.996 0.996 0.996 0.996 0.996
2 0.996 0.996 0.997 0.997 0.997 0.997 0.997 0.997
3 0.997 0.997 0.997 0.997 0.997 0.997 0.998 0.998
Y, cm 6 0.998 0.998 0.998 0.999 0.999 0.999 0.999 0.999
10 0.999 0.999 0.999 1.000 1.000 1.000 1.001 1.002
15 1.000 1.000 1.001 1.001 1.002 1.002 1.003 1.004
25 1.001 1.003 1.004 1.005 1.005 1.006 1.007 1.009
40 1.005 1.006 1.007 1.008 1.009 1.010 1.011 1.014
Table 2. Sb factors measured for an 18MV Varian 21EX and a range of field sizes. Estimated uncertainty of the data
was 0.2%.
18MV
X, cm
1 2 3 6 10 15 25 40
1 0.995 0.995 0.995 0.995 0.995 0.995 0.996 0.996
2 0.995 0.995 0.996 0.996 0.996 0.996 0.996 0.996
3 0.996 0.996 0.996 0.996 0.996 0.997 0.997 0.997
Y, cm 6 0.997 0.997 0.998 0.998 0.998 0.998 0.999 1.000
10 0.999 0.999 0.999 1.000 1.000 1.001 1.001 1.003
15 1.001 1.002 1.002 1.002 1.003 1.004 1.005 1.007
25 1.004 1.005 1.005 1.006 1.007 1.007 1.009 1.014
40 1.009 1.011 1.012 1.012 1.013 1.015 1.016 1.020
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Table 3. Sb factors measured for a 6 MV Varian TrueBeam and a range of field sizes. Estimated uncertainty of the
data was 0.1%.295
6MV
X, cm
1 2 3 6 10 15 25 40
Y, cm
1 0.988 0.988 0.988 0.988 0.988 0.988 0.988 0.989
2 0.998 0.999 0.999 0.999 0.999 0.999 0.999 1.000
3 0.998 0.999 0.999 0.999 0.999 0.999 1.000 1.000
6 0.999 0.999 0.999 0.999 1.000 1.000 1.000 1.000
10 0.999 0.999 1.000 1.000 1.000 1.000 1.000 1.001
15 0.999 1.000 1.000 1.000 1.000 1.001 1.001 1.001
25 1.000 1.000 1.001 1.001 1.001 1.001 1.001 1.002
40 1.001 1.001 1.001 1.002 1.002 1.002 1.002 1.003
Table 4. Sb factors measured for a 10MV-FFF Varian TrueBeam and a range of field sizes. Estimated uncertainty of
the data was 0.1%.
10MV-FFF
X, cm
1 2 3 6 10 15 25 40
Y, cm
1 0.993 0.993 0.993 0.993 0.993 0.994 0.994 0.994
2 0.997 0.998 0.998 0.998 0.998 0.998 0.998 0.998
3 0.998 0.998 0.998 0.998 0.998 0.998 0.999 0.999
6 0.998 0.999 0.999 0.999 0.999 0.999 0.999 1.000
10 0.999 0.999 0.999 1.000 1.000 1.000 1.001 1.001
15 1.000 1.000 1.000 1.001 1.001 1.001 1.002 1.002
25 1.001 1.001 1.002 1.002 1.002 1.003 1.003 1.004
40 1.002 1.003 1.003 1.004 1.005 1.005 1.005 1.006
Table 5. Sb factors measured for a 10MV Varian TrueBeam and a range of field sizes. Estimated uncertainty of the300
data was 0.1%.
10MV
X, cm
1 2 3 6 10 15 25 40
Y, cm
1 0.993 0.993 0.993 0.993 0.993 0.993 0.994 0.994
2 0.998 0.998 0.998 0.998 0.998 0.998 0.999 0.999
3 0.998 0.998 0.998 0.999 0.999 0.999 0.999 0.999
6 0.998 0.999 0.999 0.999 0.999 0.999 1.000 1.000
10 0.999 0.999 0.999 1.000 1.000 1.000 1.000 1.001
15 0.999 1.000 1.000 1.000 1.001 1.001 1.001 1.002
25 1.000 1.000 1.001 1.001 1.002 1.002 1.003 1.003
40 1.000 1.001 1.001 1.002 1.003 1.004 1.004 1.005
Table 6. Sb factors measured for a 15MV Varian TrueBeam and a range of field sizes. Estimated uncertainty of the
data was 0.1%.
15MV
X, cm
1 2 3 6 10 15 25 40
Y, cm
1 0.996 0.996 0.996 0.996 0.996 0.996 0.996 0.996
2 0.997 0.997 0.997 0.998 0.998 0.998 0.998 0.999
3 0.997 0.998 0.998 0.998 0.999 0.999 0.999 0.999
6 0.998 0.998 0.999 0.999 0.999 1.000 1.000 1.000
10 0.999 0.999 0.999 1.000 1.000 1.000 1.001 1.001
15 0.999 1.000 1.000 1.000 1.001 1.001 1.002 1.002
25 1.000 1.001 1.001 1.002 1.002 1.003 1.003 1.004
40 1.001 1.002 1.002 1.003 1.004 1.004 1.005 1.006
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3.3 Sb factors measured for 6MV, 10MV, 10MV-FFF and 15 MV Varian TrueBeam beams305
Sb factors that were measured for the four TrueBeam energies (6MV, 10MV-FFF, 10MV and
15MV) available in our clinic are shown in tables 3-6. These tables illustrate that the variation of
Sb factors with field size for the TrueBeam is considerably less than for the 21EX clinac. For the
lowest of our energies, 6MV, the values ranged from 0.988 (for 1 x 1 cm2) to 1.003 (for 40 x 40
cm2). For this energy it is worth noting that for the fields with Y-jaw openings exceeding 2 cm Sb310
factors could reasonably be assumed as unity. The measured Sb factors for 10MV-FFF and 10MV
were nearly identical for all fields with Y-jaw opening less than 25 cm. In the case where Y=25
cm, 10MV-FFF Sb factors exceeded those for 10MV beam by less than ~0.1%. For Y=40 cm,
10MV-FFF Sb factors were greater than those for 10MV beam by only ~0.2%. This agrees with
the previously reported similarity of 6MV and 6MV-FFF Sb factors (Titt, Vassiliev et al., 2006,315
Zhu, Kang et al., 2006). For the largest energy of 15MV, Sb factors ranged from 0.996 to 1.006.
3.4 Forward fluence values derived for two 21EX and four TrueBeam beams
The values of Dchforward previously obtained by our group via full MC simulation of the 21EX
clinac head (Popescu, Shaw et al., 2005), were 2.46x10-15 and 2.24x10-14 Gy/e- for 6MV and
18MV beams, respectively. The “optimised” values obtained from measured Sb factors as320
described in section 2.3 were 3.4x10-15 and 2.1x10-14 Gy/e. Despite the large differences between
Dchforward values obtained from full MC simulation and “optimised” ones, the resulting Sb values
agreed to within 0.5%. Both sets of Dchforward values produced Sb factors in agreement with
experiment, as seen in figures 2-3. However, as expected, measurement-based Dchforward values
resulted in better agreement with the experimental data.325
The Dchforward values were optimised to match the measured TrueBeam Sb factors, as described in
section 2.3. These values are shown in Table 7. The table also shows the number of fields that
were used to derive the measurement-based Dchforward, and the largest absolute deviation of the
Sboptimised factors (calculated using the derived Dchforward in equation (6)) from the measured Sb330
(Sbmeasured) factors.
Table 7. The Dchforward values obtained for the Varian TrueBeam clinac. Also shown are the number of fields that
were used to derive the measurement based Dchforward, and the largest absolute value of the difference between the
measured Sb factors (Sbmeasured) and the ones calculated from Dchforward (Sboptimised).335
TrueBeam energies
6MV 10MV-FFF 10MV 15MV
Dchforward (Gy/e) 1.8 x 10-14 4.78 x 10-14 4.38 x 10-14 5.32 x 10-14
Number of fields used to
derive Dchforward
25 9 17 12
max|(Sbmeasured – Sboptimized)| 0.05% 0.02% 0.08% 0.07%
As seen in the table 7, the values of Dchforward reported in this paper produced variability of Sb
factors not exceeding +/-0.1% for the range of field sizes from 1 x 40 to 40 x 1 cm2, which is
within experimental error of Sb measurement.
3.5 Monte Carlo calculated Sb factors for the Varian 21EX clinac340
Figures 2 and 3 provide comparison of the measured Sb factors for square radiation fields
produced by the Varian 21EX clinac against Monte Carlo calculated values. The “MC initial”
label is attributed to data obtained from full MC modelling with all factors required for equation
(6) obtained from MC simulation. For a 6MV beam, agreement was within 0.25% for all field
sizes except the largest one (40 x 40 cm2), where the difference was 0.54%. For 18MV,345
agreement was within 0.12% for all fields. Given that the estimated uncertainty of the MC
calculated MBSFs was 0.4% and uncertainty of measured values was 0.2%, the agreement is
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within combined MC and experimental uncertainties.
The proposed technique for determining Dchforward values from measured Sb factors (equation 7)350
was tested and found to reduce the difference between MC and experiment to be within 0.05%
for all 6MV and 0.1% for 18MV fields.
Figure 2. Comparison of measured and MC modelled Sb factors for 6MV 21EX fields. Measured data are shown as355
diamonds. Full MC modelled (squares) Sb factors were calculated using a Dchforward value of 2.46x10-15 Gy/e-. The
MC optimized (triangles) Sb factors were derived using a Dchforward value of 3.4x10-15 Gy/e that was obtained through
the fitting procedure described in section 2.3.
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Figure 3. Comparison of measured and MC modelled Sb factors for 18MV 21EX fields. Measured data are shown as
diamonds. Full MC modelled (squares) Sb factors were calculated using a Dchforward value of 2.24x10-14Gy/e-. The
MC optimized (triangles) Sb factors were derived using a Dchforward value of 2.1x10-14 Gy/e that was obtained through
the fitting procedure described in section 2.3.
5. Discussion365
In this paper, an improvement of the telescopic technique for measuring the BSR to a monitor
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chamber was reported. Compared to the previously published telescopic techniques, our method
avoided using bulky lead blocks (as in the method by Kubo), and allowed for the exclusion of
room scatter from the measured signal without the need for repeated measurements as in Yu et al.
and Sanz et al. (Yu, Sloboda et al., 1996, Sanz, Alvarez et al., 2007). Our method also enabled370
fast measurement setup that, after initial collimator alignment, only required about 20 minutes.
The small (3.1 mm) field of view to the source, small detector size, and well-type design of the
detector housing were all important components of this method that showed high reproducibility
(0.1% for TrueBeam and 0.2% for 21EX linacs) of the measured factors.
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The proposed experimental setup allowed MBSF measurements for open fields as small as 1 x 1
cm2. Accurate alignment of the collimator to the source was found to be particularly important
for the fields of this size as one of the upper jaws could partly shield primary signal. The
technique could be further refined to reduce the measurable field size by extending the SDD,
reducing detector size and reducing the collimator size. For larger fields accurate collimator380
centering becomes less critical because even if the collimator was not perfectly aligned to the
center of the source, relative detector readings would still correctly reflect the BSR effect on
radiation delivery.
The measured Sb factors were compared against values obtained by MC modelling of Varian385
21EX clinac beams. For the range of field sizes from 1 x 1 cm2 to 40 x 40 cm2 modeled in this
study, measured MBSFs agreed with MC calculated values within 0.25%, with only one value
difference (for 40 x 40 cm2 field size, 6MV beam) being 0.54%, and this agreement was within
combined statistical and experimental uncertainties (see figures 2 and 3).
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The measured Sb values for the 21EX clinac were also within 0.5% agreement with those
reported previously (Titt, Vassiliev et al., 2006, Zhu, Kang et al., 2006), and within 0.5% with
the values reported by Yu for similarly designed 2100CD (Yu, Sloboda et al., 1996). Since the
same technique was used for the TrueBeam Sb factor measurements, we feel confident in the
reported Sb factors for this machine as well.395
The MBSFs derived in this study removed up to 2.5% error for the 21EX and up to about 1% for
the TrueBeam that would have been present in absolute dose calculations had these factors been
ignored. Of particular note, these data demonstrate that the TrueBeam Sb factors have reduced
considerably compared to the 21EX clinac. In fact, for the 6MV beams with Y-jaw opening400
exceeding 1 cm, these factors could reasonably be assumed as unity. This conclusion is likely to
also be valid for 6MV-FFF beams, as 6MV and 6MV-FFF beams were previously (Titt, Vassiliev
et al., 2006, Zhu, Kang et al., 2006) shown to have a very similar magnitude of the BSR. Our
data demonstrate the same similarity of Sb factors between 10MV and 10MV-FFF beams. There
is rather little Sb variability (0.8%) for 10 MV and slightly more (1%) for 15MV beams. Due to405
the lack of manufacturer’s information on TrueBeam treatment head design we have no means to
infer the cause of the reduced TrueBeam Sb factors. Other manufacturers use designated anti-
backscatter plates positioned between the jaws and monitor chamber for this purpose. Monitor
chamber design and position along the beam axis would also affect measured MBSFs. It is
possible that TrueBeam design includes some of these modifications.410
In this paper we also demonstrate a simple technique for incorporating the measured Sb factors
into absolute dose calculations for the TrueBeam MC model (or any linac model with no
available treatment head geometries). One advantage of our approach is that once the Dchforward
value is derived for a given beam energy, no further approximations are required for absolute415
dose calibrations even in the most complex dosimetric conditions. Our “virtual linac” calibration
technique is not sensitive to the chamber geometry nor to the accuracy of Dchforward values. This
demonstrates the robustness of our MC dose calibration method that provides sub-percent
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absolute dose calculation accuracy even for relatively inaccurate values of the dose to the
monitor chamber. In our 21EX model the change of a Dchforward value by 38% resulted in less420
than 0.54% variation in Sb factors.
Since the manufacturer has not specified the TrueBeam chamber design, we used chamber
geometry from the 21EX clinac in the TrueBeam model. We are not claiming that the values of
Dchforward that we derived reflect the reality; they are simply a parameter of the MC model which425
provides accurate output calibration for a “virtual TrueBeam” MC model. Despite being
“virtual”, these values are likely to be useful to research groups that already have a model
established for the 21EX clinac while being in the process of implementing TrueBeam modelling
to their systems. In our case, the reported values of Dchforward allowed for the reproduction of
measured Sb factors in MC TrueBeam modelling for 65 tested fields across four beam energies to430
within 0.1% (table 1).
The reported values of Sb factors and Dchforward should make the implementation of this method
for accurate absolute dose calculations straightforward. Our MC absolute dose calculations for
the TrueBeam model so far (data not shown here) have excellent (within 1%) agreement with435
experiment and Eclipse calculations in the regions where such good agreement is expected.
6. Conclusions
In this paper, the Sb values measured for 6MV and 18MV beams from Varian 21EX and for four
TrueBeam energies (6MV, 10MV-FFF, 10MV, 15MV) are reported. The Sb factors were440
measured for a range of rectangular fields from 1 x 1 to 40 x 40 cm2. This set of data should be
useful for implementing Sb factors into analytical as well as MC treatment head models. Our
method of incorporating these factors into MC modelling allows for simple and natural
derivation of a single required model parameter Dchforward and avoids any empirical
approximations while providing accurate absolute dose calibration under most complex445
dosimetric conditions.
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